{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:02:44Z","timestamp":1783515764912,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ-2014-11248"],"award-info":[{"award-number":["GZ-2014-11248"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ-2014-11248"],"award-info":[{"award-number":["GZ-2014-11248"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ-2014-11248"],"award-info":[{"award-number":["GZ-2014-11248"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ-2014-11248"],"award-info":[{"award-number":["GZ-2014-11248"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["PSR-DISCCO-2019"],"award-info":[{"award-number":["PSR-DISCCO-2019"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-05918-2","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T01:01:36Z","timestamp":1728262896000},"page":"5113-5121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-599X","authenticated-orcid":false,"given":"Irene","family":"Motta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Delbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5509-3107","authenticated-orcid":false,"given":"Natalia","family":"Scaramellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4595-986X","authenticated-orcid":false,"given":"Viola","family":"Ghiandai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2008-3187","authenticated-orcid":false,"given":"Lorena","family":"Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-1272","authenticated-orcid":false,"given":"Fabio","family":"Nascimbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Lugari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-3843","authenticated-orcid":false,"given":"Dario","family":"Consonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1933-6415","authenticated-orcid":false,"given":"Elena","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-1899","authenticated-orcid":false,"given":"Valeria","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Migone De Amicis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4392-5225","authenticated-orcid":false,"given":"Elena","family":"Cassinerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7504-6407","authenticated-orcid":false,"given":"Francesca","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-6864","authenticated-orcid":false,"given":"Maria Domenica","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"issue":"9645","key":"5918_CR1","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","volume":"372","author":"GA Grabowski","year":"2008","unstructured":"Grabowski GA (2008) Phenotype, diagnosis, and treatment of Gaucher\u2019s disease. Lancet 372(9645):1263\u20131271. https:\/\/doi.org\/10.1016\/S0140-6736(08)61522-6","journal-title":"Lancet"},{"issue":"1\u20132","key":"5918_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","volume":"83","author":"E Sidransky","year":"2004","unstructured":"Sidransky E (2004) Gaucher disease: complexity in a simple disorder. Mol Genet Metab 83(1\u20132):6\u201315. https:\/\/doi.org\/10.1016\/j.ymgme.2004.08.015","journal-title":"Mol Genet Metab"},{"issue":"4","key":"5918_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bjh.12804","volume":"165","author":"AS Thomas","year":"2014","unstructured":"Thomas AS, Mehta A, Hughes DA (2014) Gaucher disease: haematological presentations and complications. Br J Haematol 165(4):427\u2013440. https:\/\/doi.org\/10.1111\/bjh.12804","journal-title":"Br J Haematol"},{"issue":"3","key":"5918_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1046\/j.1365-2141.1999.01616.x","volume":"106","author":"Y Gielchinsky","year":"1999","unstructured":"Gielchinsky Y, Elstein D, Hadas-Halpern I, Lahad A, Abrahamov A, Zimran A (1999) Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with gaucher disease. Br J Haematol 106(3):812\u2013816. https:\/\/doi.org\/10.1046\/j.1365-2141.1999.01616.x","journal-title":"Br J Haematol"},{"issue":"12","key":"5918_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3324\/haematol.2016.147546","volume":"101","author":"N Reihani","year":"2016","unstructured":"Reihani N, Arlet JB, Dussiot M, de Villemeur TB, Belmatoug N, Rose C, Colin-Aronovicz Y, Le Van Hermine O, Franco M (2016) Unexpected macrophage-independent dyserythropoiesis in Gaucher disease. Haematologica 101(12):1489\u20131498. https:\/\/doi.org\/10.3324\/haematol.2016.147546","journal-title":"Haematologica"},{"issue":"3","key":"5918_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1182\/blood-2012-07-442467","volume":"121","author":"M Franco","year":"2013","unstructured":"Franco M, Collec E, van den Connes P, Billette de Villemeur T, Belmatoug N, von Lindern M, Ameziane N, Hermine O, Le Van Colin Y, Mignot C (2013) Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease. Blood 121(3):546\u2013555. https:\/\/doi.org\/10.1182\/blood-2012-07-442467","journal-title":"Blood"},{"key":"5918_CR7","doi-asserted-by":"publisher","unstructured":"Dupuis L, Chauvet M, Bourdelier E, Dussiot M, Le Van Belmatoug N, Chene A, Franco M (2022) Phagocytosis of erythrocytes from Gaucher patients induces phenotypic modifications in macrophages, driving them toward Gaucher cells. Int J Mol Sci 23(14). https:\/\/doi.org\/10.3390\/ijms23147640","DOI":"10.3390\/ijms23147640"},{"issue":"8","key":"5918_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.5966\/sctm.2014-0213","volume":"4","author":"JA Sgambato","year":"2015","unstructured":"Sgambato JA, Park TS, Miller D, Panicker LM, Sidransky E, Lun Y, Awad O, Bentzen SM, Zambidis ET, Feldman RA (2015) Gaucher Disease-Induced pluripotent stem cells display decreased erythroid potential and aberrant myelopoiesis. Stem Cells Transl Med 4(8):878\u2013886. https:\/\/doi.org\/10.5966\/sctm.2014-0213","journal-title":"Stem Cells Transl Med"},{"key":"5918_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bcmd.2016.10.010","volume":"68","author":"F Lorenz","year":"2018","unstructured":"Lorenz F, Pawlowicz E, Klimkowska M, Beshara S, Bulanda Brustad A, Skotnicki AB, Wahlin A, Machaczka M (2018) Ferritinemia and serum inflammatory cytokines in Swedish adults with gaucher disease type 1. Blood Cells Mol Dis 68:35\u201342. https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.010","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"5918_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ajh.25752","volume":"95","author":"G Marchi","year":"2020","unstructured":"Marchi G, Nascimbeni F, Motta I, Busti F, Carubbi F, Cappellini MD, Pietrangelo A, Corradini E, Piperno A, Girelli D (2020) Hyperferritinemia and diagnosis of type 1 gaucher disease. Am J Hematol 95(5):570\u2013576. https:\/\/doi.org\/10.1002\/ajh.25752","journal-title":"Am J Hematol"},{"issue":"1","key":"5918_CR11","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1038\/s41598-021-82296-z","volume":"11","author":"I Motta","year":"2021","unstructured":"Motta I, Consonni D, Stroppiano M, Benedetto C, Cassinerio E, Tappino B, Ranalli P, Borin L, Facchini L, Patriarca A, Barcellini W, Lanza F, Filocamo M, Cappellini MD, Splenomegaly Gaucher g (2021) Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia. Sci Rep 11(1):2594. https:\/\/doi.org\/10.1038\/s41598-021-82296-z","journal-title":"Sci Rep"},{"issue":"4","key":"5918_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3324\/haematol.2017.177816","volume":"103","author":"T Lefebvre","year":"2018","unstructured":"Lefebvre T, Reihani N, Daher R, de Villemeur TB, Belmatoug N, Rose C, Colin-Aronovicz Y, Le Van Puy H, Franco M, Karim Z (2018) Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease. Haematologica 103(4):587\u2013596. https:\/\/doi.org\/10.3324\/haematol.2017.177816","journal-title":"Haematologica"},{"issue":"6","key":"5918_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0002-9343(67)90070-8","volume":"42","author":"RE Lee","year":"1967","unstructured":"Lee RE, Balcerzak SP, Westerman MP (1967) Gaucher\u2019s disease. A morphologic study and measurements of iron metabolism. Am J Med 42(6):891\u2013898. https:\/\/doi.org\/10.1016\/0002-9343(67)90070-8","journal-title":"Am J Med"},{"key":"5918_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-53-2-293","volume":"53","author":"M Lorber","year":"1960","unstructured":"Lorber M (1960) The occurrence of intracellular iron in Gaucher\u2019s disease. Ann Intern Med 53:293\u2013305. https:\/\/doi.org\/10.7326\/0003-4819-53-2-293","journal-title":"Ann Intern Med"},{"issue":"10","key":"5918_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.5858\/2004-128-1191-EIGC","volume":"128","author":"A Bitton","year":"2004","unstructured":"Bitton A, Etzell J, Grenert JP, Wang E (2004) Erythrophagocytosis in gaucher cells. Arch Pathol Lab Med 128(10):1191\u20131192. https:\/\/doi.org\/10.5858\/2004-128-1191-EIGC","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"5918_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cyto.b.20539","volume":"80","author":"D Bratosin","year":"2011","unstructured":"Bratosin D, Tissier JP, Lapillonne H, Hermine O, de Villemeur TB, Cotoraci C, Montreuil J, Mignot C (2011) A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis. Cytometry B Clin Cytom 80(1):28\u201337. https:\/\/doi.org\/10.1002\/cyto.b.20539","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"5918_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.blre.2016.05.003","volume":"30","author":"M Regenboog","year":"2016","unstructured":"Regenboog M, van Kuilenburg AB, Verheij J, Swinkels DW, Hollak CE (2016) Hyperferritinemia and iron metabolism in Gaucher disease: potential pathophysiological implications. Blood Rev 30(6):431\u2013437. https:\/\/doi.org\/10.1016\/j.blre.2016.05.003","journal-title":"Blood Rev"},{"issue":"7","key":"5918_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ajh.21721","volume":"85","author":"P Stein","year":"2010","unstructured":"Stein P, Yu H, Jain D, Mistry PK (2010) Hyperferritinemia and iron overload in type 1 gaucher disease. Am J Hematol 85(7):472\u2013476. https:\/\/doi.org\/10.1002\/ajh.21721","journal-title":"Am J Hematol"},{"issue":"9","key":"5918_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/ajh.26276","volume":"96","author":"PK Mistry","year":"2021","unstructured":"Mistry PK, Lukina E, Ben Turkia H, Shankar SP, Baris Feldman H, Ghosn M, Mehta A, Packman S, Lau H, Petakov M, Assouline S, Balwani M, Danda S, Hadjiev E, Ortega A, Foster MC, Gaemers SJM, Peterschmitt MJ (2021) Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: phase 3 ENGAGE trial final results. Am J Hematol 96(9):1156\u20131165. https:\/\/doi.org\/10.1002\/ajh.26276","journal-title":"Am J Hematol"},{"issue":"2","key":"5918_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/s0002-9343(02)01150-6","volume":"113","author":"NJ Weinreb","year":"2002","unstructured":"Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Zimran A (2002) Effectiveness of enzyme replacement therapy in 1028 patients with type 1 gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 113(2):112\u2013119. https:\/\/doi.org\/10.1016\/s0002-9343(02)01150-6","journal-title":"Am J Med"},{"key":"5918_CR21","first-page":"5","volume":"405","author":"Nutritional anaemias","year":"1968","unstructured":"Nutritional anaemias (1968) Report of a WHO scientific group. World Health Organ Tech Rep Ser 405:5\u201337","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"5","key":"5918_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41574-023-00807-6","volume":"19","author":"L Valenti","year":"2023","unstructured":"Valenti L, Corradini E, Adams LA, Aigner E, Alqahtani S, Arrese M, Bardou-Jacquet E, Bugianesi E, Fernandez-Real JM, Girelli D, Hagstrom H, Henninger B, Kowdley K, Ligabue G, McClain D, Laine F, Miyanishi K, Muckenthaler MU, Pagani A, Pedrotti P, Pietrangelo A, Prati D, Ryan JD, Silvestri L, Spearman CW, Stal P, Tsochatzis EA, Vinchi F, Zheng MH, Zoller H (2023) Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nat Rev Endocrinol 19(5):299\u2013310. https:\/\/doi.org\/10.1038\/s41574-023-00807-6","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"5918_CR23","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"CE Hollak","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93(3):1288\u20131292. https:\/\/doi.org\/10.1172\/JCI117084","journal-title":"J Clin Invest"},{"issue":"6","key":"5918_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jbmr.3734","volume":"34","author":"D Hughes","year":"2019","unstructured":"Hughes D, Mikosch P, Belmatoug N, Carubbi F, Cox T, Goker-Alpan O, Kindmark A, Mistry P, Poll L, Weinreb N, Deegan P (2019) Gaucher Disease in bone: from pathophysiology to practice. J Bone Min Res 34(6):996\u20131013. https:\/\/doi.org\/10.1002\/jbmr.3734","journal-title":"J Bone Min Res"},{"issue":"19","key":"5918_CR25","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1182\/blood-2018-04-842997","volume":"132","author":"DL Zhang","year":"2018","unstructured":"Zhang DL, Ghosh MC, Ollivierre H, Li Y, Rouault TA (2018) Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress. Blood 132(19):2078\u20132087. https:\/\/doi.org\/10.1182\/blood-2018-04-842997","journal-title":"Blood"},{"key":"5918_CR26","doi-asserted-by":"publisher","unstructured":"Lakhal-Littleton S, Wolna M, Chung YJ, Christian HC, Heather LC, Brescia M, Ball V, Diaz R, Santos A, Biggs D, Clarke K, Davies B, Robbins PA (2016) An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. Elife 5. https:\/\/doi.org\/10.7554\/eLife.19804","DOI":"10.7554\/eLife.19804"},{"issue":"13","key":"5918_CR27","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1182\/blood.2019003907","volume":"136","author":"L Kammerer","year":"2020","unstructured":"Kammerer L, Mohammad G, Wolna M, Robbins PA, Lakhal-Littleton S (2020) Fetal liver hepcidin secures iron stores in utero. Blood 136(13):1549\u20131557. https:\/\/doi.org\/10.1182\/blood.2019003907","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05918-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:10:50Z","timestamp":1735866650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5918"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05918-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"8 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical review committee of the center \u201cComitato Etico Milano Area 2\u201d (Protocol number 1678\/2016) and was carried out in compliance with the principles established in the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Irene Motta has been or is a current consultant for Sanofi, Bristol Myers Squibb, and Amicus Therapeutics and has received honoraria for lectures, financial support, and grants from Sanofi.Fabio Nascimbeni has been or is a current consultant for Sanofi.Francesca Carubbi received financial support and grants from Sanofi, Amgen.Maria Domenica Cappellini has been or is a current consultant for Sanofi, Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma and Ionis Pharmaceuticals, and received research funding from Sanofi, Novartis, Celgene Corp (Bristol Myers Squibb), La Jolla Pharmaceutical Company, Roche, Protagonist Therapeutics, and CRISPR Therapeutics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}